| Purpose | Announcement Date | Meeting Date |
|---|---|---|
| EGM | 8 Jan 2025 | 3 Feb 2025 |
| Ajooni Biotech Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on February 03, 2025 Ajooni Biotech Limited has informed the Exchange regarding Intimation of issuance of Corrigendum to the Notice of the 01st Extra Ordinary General Meeting . (As Per NSE Announcement Dated on: 29/01/2025) Ajooni Biotech Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on February 03, 2025 (As Per NSE Announcement Dated on: 03/02/2025) Ajooni Biotech Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on February 03, 2025. Further, the company has informed the Exchange regarding voting results. (As Per NSE Announcement Dated on: 04/02/2025) Ajooni Biotech Limited has informed the Exchange regarding Appointment of Mr Ishtneet Bhatia as Non- Executive Independent Director of the company w.e.f. January 03, 2025. (As Per NSE Announcement Dated on: 05/02/2025) Ajooni Biotech Limited has informed the Exchange regarding Disclosure of events . (As Per NSE Announcement Dated on: 06.02.2025) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
